Operating Income - Bergenbio ASA (OSE:BGBIO) - Alpha Spread
B

Bergenbio ASA
OSE:BGBIO

Watchlist Manager
Bergenbio ASA
OSE:BGBIO
Watchlist
Price: 9.07 NOK 1.06% Market Closed
Market Cap: 368.3m NOK
Have any thoughts about
Bergenbio ASA?
Write Note

Bergenbio ASA
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bergenbio ASA
Operating Income Peer Comparison

Comparables:
HBC
L
LYTIX
AZT
N
NYKD
T
TRMED

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
B
Bergenbio ASA
OSE:BGBIO
Operating Income
-kr159.2m
CAGR 3-Years
18%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Operating Income
-kr92.3m
CAGR 3-Years
3%
CAGR 5-Years
-4%
CAGR 10-Years
-9%
L
Lytix Biopharma AS
OSE:LYTIX
Operating Income
-kr96.8m
CAGR 3-Years
-32%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Operating Income
kr12.1m
CAGR 3-Years
-41%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
N
Nykode Therapeutics ASA
OSE:NYKD
Operating Income
-$59m
CAGR 3-Years
N/A
CAGR 5-Years
-57%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Operating Income
-kr35m
CAGR 3-Years
57%
CAGR 5-Years
37%
CAGR 10-Years
-7%

See Also

What is Bergenbio ASA's Operating Income?
Operating Income
-159.2m NOK

Based on the financial report for Mar 31, 2024, Bergenbio ASA's Operating Income amounts to -159.2m NOK.

What is Bergenbio ASA's Operating Income growth rate?
Operating Income CAGR 5Y
3%

Over the last year, the Operating Income growth was 47%. The average annual Operating Income growth rates for Bergenbio ASA have been 18% over the past three years , 3% over the past five years .

Back to Top